Authors: Buckner, JC Schomberg, PJ McGinnis, WL Cascino, TL Scheithauer, BW O'Fallon, JR Morton, RF Kuross, SA Mailliard, JA Hatfield, AK Cole, JT Steen, PD Bernath, AM

Citation: Jc. Buckner et al., A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosedhigh-grade glioma, CANCER, 92(2), 2001, pp. 420-433

Authors: Burch, PA Bernath, AM Cascino, TL Scheithauer, BW Novotny, P Nair, S Buckner, JC Pfeifle, DM Kugler, JW Tschetter, LK

Citation: Pa. Burch et al., A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas, INV NEW DR, 18(3), 2000, pp. 275-280

Authors: Prados, MD Scott, C Sandler, H Buckner, JC Phillips, T Schultz, C Urtasun, R Davis, R Gutin, P Cascino, TL Greenberg, HS Curran, WJ

Citation: Md. Prados et al., A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: A preliminary report of RTOG 9404, INT J RAD O, 45(5), 1999, pp. 1109-1115

Authors: Rajkumar, SV Buckner, JC Schomberg, PJ Pitot, HC Ingle, JN Cascino, TL

Citation: Sv. Rajkumar et al., Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas, NEUROSURGER, 44(1), 1999, pp. 67-73

Authors: Buckner, JC Malkin, MG Reed, E Cascino, TL Reid, JM Ames, MM Tong, WPY Lim, S Figg, WD

Citation: Jc. Buckner et al., Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma, MAYO CLIN P, 74(2), 1999, pp. 137-145

Authors: Rajkumar, SV Buckner, JC Schomberg, PJ Reid, JM Bagniewski, PJ Ames, MM Cascino, TL Marks, RS

Citation: Sv. Rajkumar et al., Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma, INT J RAD O, 42(5), 1998, pp. 969-975